The BIOMAP project has successfully concluded.

Read this article to learn more about the impact of BIOMAP and view our results in the publication section.

Stay tuned for more results to come. We will continue to update the publication section and inform you via our LinkedIn account when new results are published.

Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.

With a total of 200 employees, Hahn-Schickard is a well-known R+D service provider at three sites in the Southwest of Germany: in Stuttgart, Villingen-Schwenningen, and Freiburg. In trustworthy cooperation with industry, Hahn-Schickard develops innovative products and technologies in research fields with a strong future impact such as Internet of Things, sustainable mobility, environmental and natural resources, healthcare as well as information and communication technologies. Hahn-Schickard offers the production of small and medium-sized series as well as the transition into mass production. With a flexible pilot line Hahn-Schickard manufactures lab-on-a-chip systems for clinical and diagnostic purposes under clean room conditions at the site in Freiburg.

Role within BIOMAP

In the BIOMAP project Hahn-Schickard will realize the clinical translation by miniaturizing and automating the defined assay for biomarker validation integrating it into the LabDisk platform, a lab-on-a-chip system that allows for an automation with minimum user interface and a maximum reproducibility of the sample preparation and the classifier assay developed in this project.